A new publication shines a spotlight on HER3, a long-overlooked member of the ErbB receptor family, revealing its critical role in cancer progression and resistance to therapy.

Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases; Strengthens QIAGEN Digital Insights offering for small and mid- ...

Influencer Tanner Martin, who was diagnosed with stage 4 colon cancer at age 25 in November 2020, is expecting his firstborn ...

Cena, 48, was diagnosed with melanoma twice, first with a spot on his left pectoral muscle and again a year later when another spot on his left upper trapezius muscle was also cancerous. 'I received ...

A stunning new genetic study is shaking up everything we thought we knew about Japan’s origins.

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. Increasing adoption of CAR-T cell therapies, ...

SPONSORED – BioBalance Health, the first estrogen and testosterone pellet practice in St. Louis, offers the latest treatments for a variety of health concerns—from cancer screening to genetic ...

Researchers at Novartis BioMedical Research in the US and Switzerland have identified a molecular target that may provide a ...

A toddler was diagnosed with eye cancer after his parents noticed a white glow in his left eye. Shane Stevenson, 35, and his ...

Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug ...